Gonadotropin Releasing Hormone Analog (GnRH-a)
Synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone
Lupron©, Lupron Depot©, Goserelin©, Naferelin©, Synarel©, Zoladex©
Subcutaneous or intramuscular injection (Lupron, Antagon); nasal spray (Naferelin, Synarel); skin-implants (Goserelin, Zoladex)
Uterine fibroids; Endometriosis; Demonstrated weak hormonal signal between the hypothalamus, pituitary, and ovarian systems with:
- no current pregnancy
- no hypersensitivity to GnRH or related drugs, or to benzyl alcohol
- no abnormal vaginal bleeding
Endometriosis clinical symptoms; Synchronizing ovulatory cycles intended for fertility treatment (Controlled ovarian hyperstimulation or COH)
How does it work?
Suppresses pituitary secretion of gonadotropins (reproductive hormones) and halts menstrual cycle. Estrogen level decreases to menopause levels. Endometrium does not grow, ovulation does not occur.
- existence of current pregnancy
- urinary tract obstruction
- testosterone levels
- serum testosterone & acid phosphatase levels
- estrogen level
- Injectables - From 3.75 mg once a month for six months to 11.25 mg every three months for six months (if intramuscular), or 1 mg subcutaneous once daily during early to mid-follicular phase, depending on diagnosis.
- Nasal Sprays - One (1) 200 mcg spray into one nostril in the morning, and one spray in the other nostril in evening, for 6 months.
- Implants - One (1) 3.6 mg implant injected under skin in upper abdomen every 28 days for six months.
- Follow instructions for injectable drugs.
- Nasal Sprays
- Begin treatment on Day 2, 3, or 4 of menstrual cycle. Do not double doses if missed a dose.
Common side effects
- Hot flashes
- Night sweats
- Emotional irritability
- Breast size changes
- Decreased libido
- Vaginal dryness
- Sore muscles
Side effects to report to your doctor
- Heart palpitations
- Extreme anxiety or depression
- Shortness of breath or tight chest
- Numbness or tingling of hands or feet
- Skin rash, hives, or itching
- Abdominal pain or swelling
- Category X: If taken during pregnancy, may cause birth defects.
- Should not be used by women who are breastfeeding.
- Results in small loss in bone density, some of which may not be reversible. Patients with osteoporosis risk factors are advised to avoid GnRH-a use beyond six months.
- May cause temporary increase in endometriosis pain at beginning of treatment.
Drug interactions or incompatibility
No known drug interactions
© Tracy Morris